Development of a prognostic signature for overall survival using peripheral blood biomarkers in head and neck squamous cell carcinoma treated with immune checkpoint inhibitors. - Pan C; Ng K; Voutsinas J; Barber B; Rizvi ZH; Marchiano E; Ferrandino RM; Futran N; Laramore GE; Liao JJ; Parvathaneni U; Panjwani N; et al. (BMC cancer, 2024)